CMS demo could pave the path to eliminating Part D rebates

The Trump administration is laying the groundwork to put policies in place in 2020 that would reduce out-of-pocket spending by senior citizens with high drug costs, boost drug company revenues -- and shift undetermined costs to taxpayers.